Literature DB >> 27446283

Prognostic factors affecting early colectomy in patients with moderate to severe ulcerative colitis treated with calcineurin inhibitors.

Hiromitsu Ban1, Shigeki Bamba2, Atsushi Nishida2, Osamu Inatomi2, Makoto Shioya2, Ken-Ichiro Takahashi2, Hirotsugu Imaeda2, Masaki Murata2, Masaya Sasaki3, Tomoyuki Tsujikawa4, Akira Andoh2.   

Abstract

Calcineurin inhibitors (CNIs) such as cyclosporine A (CSA) and tacrolimus (FK506) are often used as a second-line drug for steroid-refractory or steroid-dependent patients with ulcerative colitis (UC). The aim of the present study was to determine the prognostic factors for early colectomy. A total of 85 hospitalized patients with UC (CSA, 50 patients; FK506, 35 patients) were enrolled. Colectomy carried out within 60 days of starting CNI therapy was defined as 'early colectomy'. To assess the prognostic factors affecting early colectomy, clinical practical variables, including the Onodera-prognostic nutritional index (O-PNI): 10xAlb+0.005× (total lymphocyte count), were analyzed. The results demonstrated that the significant factors predicting early colectomy were i) disease severity, ii) immunomodulator-naïve history, iii) lower serum hematocrit, iv) lower serum albumin and v) lower O-PNI. In addition, the significant factors predicting overall colectomy were as follows: i) C7-HRP positivity and ii) >10,000 mg of prednisolone used prior to the initiation of CNI treatment. The combination of hematocrit and O-PNI enhanced the prediction of early colectomy. Clinical variables such as hematocrit and O-PNI were the significant factors predicting colectomy. These results may be used as a guide to predict the outcome of patients with UC in clinical settings.

Entities:  

Keywords:  calcineurin inhibitors; colectomy; cyclosporine A; tacrolimus; ulcerative colitis

Year:  2016        PMID: 27446283      PMCID: PMC4950154          DOI: 10.3892/etm.2016.3341

Source DB:  PubMed          Journal:  Exp Ther Med        ISSN: 1792-0981            Impact factor:   2.447


  30 in total

1.  The second European evidence-based Consensus on the diagnosis and management of Crohn's disease: Current management.

Authors:  A Dignass; G Van Assche; J O Lindsay; M Lémann; J Söderholm; J F Colombel; S Danese; A D'Hoore; M Gassull; F Gomollón; D W Hommes; P Michetti; C O'Morain; T Oresland; A Windsor; E F Stange; S P L Travis
Journal:  J Crohns Colitis       Date:  2010-01-15       Impact factor: 9.071

Review 2.  Treatment guidelines in inflammatory bowel disease: the Japanese perspectives.

Authors:  Katsuyoshi Matsuoka; Toshifumi Hibi
Journal:  Dig Dis       Date:  2013-11-14       Impact factor: 2.404

3.  Ulcerative colitis practice guidelines in adults: American College Of Gastroenterology, Practice Parameters Committee.

Authors:  Asher Kornbluth; David B Sachar
Journal:  Am J Gastroenterol       Date:  2010-01-12       Impact factor: 10.864

4.  Decreasing colectomy rates for ulcerative colitis: a population-based time trend study.

Authors:  Gilaad G Kaplan; Cynthia H Seow; Subrata Ghosh; Natalie Molodecky; Ali Rezaie; Gordon W Moran; Marie-Claude Proulx; James Hubbard; Anthony MacLean; Donald Buie; Remo Panaccione
Journal:  Am J Gastroenterol       Date:  2012-11-20       Impact factor: 10.864

Review 5.  Update on biologic pathways in inflammatory bowel disease and their therapeutic relevance.

Authors:  Matthew J Hamilton; Scott B Snapper; Richard S Blumberg
Journal:  J Gastroenterol       Date:  2012-01-05       Impact factor: 7.527

6.  The nutritional index 'CONUT' is useful for predicting long-term prognosis of patients with end-stage liver diseases.

Authors:  Koji Fukushima; Yoshiyuki Ueno; Naoki Kawagishi; Yasuteru Kondo; Jun Inoue; Eiji Kakazu; Masashi Ninomiya; Yuta Wakui; Naoko Saito; Susumu Satomi; Tooru Shimosegawa
Journal:  Tohoku J Exp Med       Date:  2011-07       Impact factor: 1.848

7.  Infliximab or cyclosporine for acute severe ulcerative colitis: a retrospective analysis.

Authors:  Kathryn E Dean; Joanna Hikaka; John T Huakau; Russell S Walmsley
Journal:  J Gastroenterol Hepatol       Date:  2012-03       Impact factor: 4.029

8.  Ciclosporin versus infliximab in patients with severe ulcerative colitis refractory to intravenous steroids: a parallel, open-label randomised controlled trial.

Authors:  David Laharie; Arnaud Bourreille; Julien Branche; Matthieu Allez; Yoram Bouhnik; Jerome Filippi; Frank Zerbib; Guillaume Savoye; Maria Nachury; Jacques Moreau; Jean-Charles Delchier; Jacques Cosnes; Elena Ricart; Olivier Dewit; Antonio Lopez-Sanroman; Jean-Louis Dupas; Franck Carbonnel; Gilles Bommelaer; Benoit Coffin; Xavier Roblin; Gert Van Assche; Maria Esteve; Martti Färkkilä; Javier P Gisbert; Philippe Marteau; Stephane Nahon; Martine de Vos; Denis Franchimont; Jean-Yves Mary; Jean-Frederic Colombel; Marc Lémann
Journal:  Lancet       Date:  2012-10-10       Impact factor: 79.321

9.  Prognostic factors for colectomy in refractory ulcerative colitis treated with calcineurin inhibitors.

Authors:  Shigeki Bamba; Akira Andoh; Hirotsugu Imaeda; Hiromitsu Ban; Ayako Kobori; Yousuke Mochizuki; Makoto Shioya; Takashi Nishimura; Osamu Inatomi; Masaya Sasaki; Yasuharu Saitoh; Tomoyuki Tsujikawa; Yoshihide Fujiyama
Journal:  Exp Ther Med       Date:  2012-04-11       Impact factor: 2.447

10.  Predictive factors of response to intravenous ciclosporin in severe ulcerative colitis: the development of a novel prediction formula.

Authors:  K Saito; T Katsuno; T Nakagawa; M Saito; S Sazuka; T Sato; T Matsumura; M Arai; H Miyauchi; H Matsubara; O Yokosuka
Journal:  Aliment Pharmacol Ther       Date:  2012-09-07       Impact factor: 8.171

View more
  3 in total

1.  Sarcopenia is a predictive factor for intestinal resection in admitted patients with Crohn's disease.

Authors:  Shigeki Bamba; Masaya Sasaki; Azusa Takaoka; Kenichiro Takahashi; Hirotsugu Imaeda; Atsushi Nishida; Osamu Inatomi; Mitsushige Sugimoto; Akira Andoh
Journal:  PLoS One       Date:  2017-06-23       Impact factor: 3.240

2.  Lymphocyte to monocyte ratio and serum albumin changes predict tacrolimus therapy outcomes in patients with ulcerative colitis.

Authors:  Natsuki Ishida; Shinya Tani; Yusuke Asai; Takahiro Miyazu; Satoshi Tamura; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  Sci Rep       Date:  2022-08-09       Impact factor: 4.996

3.  Early serum albumin changes in patients with ulcerative colitis treated with tacrolimus will predict clinical outcome.

Authors:  Natsuki Ishida; Takahiro Miyazu; Satoshi Tamura; Shinya Tani; Mihoko Yamade; Moriya Iwaizumi; Yasushi Hamaya; Satoshi Osawa; Takahisa Furuta; Ken Sugimoto
Journal:  World J Gastroenterol       Date:  2021-06-14       Impact factor: 5.742

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.